Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.1275 0 (0%) Market Cap: 20.04 Bil Enterprise Value: 23.95 Bil PE Ratio: 56.39 PB Ratio: 2.01 GF Score: 87/100

Q1 2021 Astellas Pharma Inc Earnings Call Transcript

Aug 04, 2020 / 07:00AM GMT
Release Date Price: $15.82
Unidentified Company Representative

[Interpreted] Thank you very much for waiting. We are going to begin. Thank you very much for joining this conference call hosted by Astellas Pharma Inc. despite your very busy schedule. I'm [Fujii] from Corporate Advocacy and Relation. I'm delighted to serve as emcee today. We are starting this meeting to explain our financial year 2020 first quarter financial results we announced at noon today. We are going to explain based on materials posted in the IR Library Business Results section on our website, so please refer to the documents.

Let me introduce the participants first. CSTO and CFO, Naoki Okamura. Okamura, thank you for your time. CCO, Yukio Matsui. Matsui, thank you for joining. Development Division, Global Head of Project Management, Minetake Kitagawa.

Mike Kitagawa
Astellas Pharma Inc. - Senior VP of Development Project Management

[Interpreted] Kitagawa speaking. Thank you for your time.

Unidentified Company Representative

[Interpreted] This material or presentation by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot